Coeptis Therapeutics Holdings (COEP) Debt to Equity (2021 - 2025)
Coeptis Therapeutics Holdings (COEP) has 5 years of Debt to Equity data on record, last reported at $0.01 in Q3 2025.
- For Q3 2025, Debt to Equity fell 54.36% year-over-year to $0.01; the TTM value through Sep 2025 reached $0.01, down 54.36%, while the annual FY2024 figure was $0.35, 91.17% up from the prior year.
- Debt to Equity reached $0.01 in Q3 2025 per COEP's latest filing, down from $0.02 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.7 in Q4 2021 and bottomed at -$0.48 in Q2 2024.
- Average Debt to Equity over 5 years is $0.09, with a median of $0.08 recorded in 2023.
- Peak YoY movement for Debt to Equity: surged 447.12% in 2023, then crashed 732.28% in 2024.
- A 5-year view of Debt to Equity shows it stood at $0.7 in 2021, then tumbled by 95.2% to $0.03 in 2022, then soared by 447.12% to $0.18 in 2023, then skyrocketed by 91.17% to $0.35 in 2024, then plummeted by 96.1% to $0.01 in 2025.
- Per Business Quant database, its latest 3 readings for Debt to Equity were $0.01 in Q3 2025, $0.02 in Q2 2025, and $0.11 in Q1 2025.